Marshall Wace’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.5M Sell
1,018,847
-139,015
-12% -$887K 0.01% 937
2025
Q1
$5.63M Sell
1,157,862
-170,779
-13% -$830K 0.01% 934
2024
Q4
$12.7M Sell
1,328,641
-1,165,943
-47% -$11.1M 0.02% 654
2024
Q3
$20.8M Buy
2,494,584
+1,951,771
+360% +$16.3M 0.03% 452
2024
Q2
$3.7M Buy
542,813
+233,341
+75% +$1.59M ﹤0.01% 1017
2024
Q1
$783K Buy
309,472
+231,294
+296% +$585K ﹤0.01% 1531
2023
Q4
$188K Sell
78,178
-81,602
-51% -$196K ﹤0.01% 1679
2023
Q3
$543K Sell
159,780
-25,784
-14% -$87.7K ﹤0.01% 1423
2023
Q2
$1.36M Buy
185,564
+173,732
+1,468% +$1.28M ﹤0.01% 1282
2023
Q1
$123K Buy
+11,832
New +$123K ﹤0.01% 1986
2022
Q3
Sell
-448,533
Closed -$13.9M 2670
2022
Q2
$13.9M Buy
+448,533
New +$13.9M 0.03% 600
2022
Q1
Sell
-20,519
Closed -$893K 2775
2021
Q4
$893K Sell
20,519
-102,200
-83% -$4.45M ﹤0.01% 1947
2021
Q3
$6.15M Buy
122,719
+11,296
+10% +$566K 0.03% 731
2021
Q2
$7.02M Buy
+111,423
New +$7.02M 0.03% 585
2020
Q1
Sell
-163,975
Closed -$8.85M 1703
2019
Q4
$8.85M Sell
163,975
-130,267
-44% -$7.03M 0.06% 310
2019
Q3
$15.4M Buy
294,242
+218,936
+291% +$11.4M 0.12% 187
2019
Q2
$3.64M Buy
+75,306
New +$3.64M 0.03% 571
2015
Q3
Sell
-16,729
Closed -$551K 953
2015
Q2
$551K Buy
+16,729
New +$551K 0.01% 693
2014
Q4
Sell
-33,002
Closed -$703K 850
2014
Q3
$703K Sell
33,002
-109,648
-77% -$2.34M 0.01% 603
2014
Q2
$3.2M Buy
+142,650
New +$3.2M 0.05% 326